173 related articles for article (PubMed ID: 32676746)
1. A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.
Wang T; Lyu CY; Jiang YH; Dong XY; Wang Y; Li ZH; Wang JX; Xu RR
Mol Divers; 2021 Nov; 25(4):2351-2365. PubMed ID: 32676746
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification.
Zhang J; Qi C; Li H; Ding C; Wang L; Wu H; Dai W; Wang C
Medicine (Baltimore); 2023 Dec; 102(51):e36656. PubMed ID: 38134066
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology-based strategy to investigate the active ingredients and molecular mechanisms of Scutellaria Barbata D. Don against radiation pneumonitis.
Sun PY; Wang AS; Zhang ZF; Zhang YL; Zheng X
Medicine (Baltimore); 2021 Nov; 100(47):e27957. PubMed ID: 34964782
[TBL] [Abstract][Full Text] [Related]
4. Study on the mechanism of action of
Yang AY; Liu HL; Yang YF
Front Pharmacol; 2022; 13():1072547. PubMed ID: 36699068
[No Abstract] [Full Text] [Related]
5. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W
J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of "Scutellaria barbata-Hedyotis diffusa" against breast cancer based on network pharmacology].
Jing XU; Feng-Qin S; Ke-Xin DU; Jia D; Dong-Yun LI
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4448-4454. PubMed ID: 33164375
[TBL] [Abstract][Full Text] [Related]
7. Molecular Assessment of
Shi H; Liu J; Fan J; He L; Wang X; Tang F; Tian D; He Y
Evid Based Complement Alternat Med; 2022; 2022():1988378. PubMed ID: 35178099
[TBL] [Abstract][Full Text] [Related]
8. A
Liu J; Jiang M; Li Z; Zhang X; Li X; Hao Y; Su X; Zhu J; Zheng C; Xiao W; Wang Y
Front Pharmacol; 2018; 9():1473. PubMed ID: 30618763
[TBL] [Abstract][Full Text] [Related]
9. Study on the Mechanism of Competing Endogenous Network of 'Scutellaria barbata D.Don-Houttuynia cordata- Radix Scutellariae' in the Treatment of NSCLC based on Bioinformatics, Molecular Dynamics and Experimental Verification.
Wu L; Xu B; Qi Y; Yuan C
Curr Comput Aided Drug Des; 2024 Apr; ():. PubMed ID: 38685811
[TBL] [Abstract][Full Text] [Related]
10. AURKB, CHEK1 and NEK2 as the Potential Target Proteins of
Huang C; Luo H; Huang Y; Fang C; Zhao L; Li P; Zhong C; Liu F
Int J Gen Med; 2021; 14():3295-3312. PubMed ID: 34285555
[TBL] [Abstract][Full Text] [Related]
11. Integrating chemical profiling and network pharmacology analysis based on anti-inflammatory effects for quality control of Scutellaria barbata.
Li T; Yang WZ; Song TX; Liu CJ; Jiang MM
Phytochem Anal; 2021 Nov; 32(6):1141-1151. PubMed ID: 33949013
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor effect of Scutellaria barbata D. Don extracts on ovarian cancer and its phytochemicals characterisation.
Zhang L; Ren B; Zhang J; Liu L; Liu J; Jiang G; Li M; Ding Y; Li W
J Ethnopharmacol; 2017 Jul; 206():184-192. PubMed ID: 28571726
[TBL] [Abstract][Full Text] [Related]
13. Scutellaria barbata D. Don (SBD) protects oxygen glucose deprivation/reperfusion-induced injuries of PC12 cells by up-regulating Nrf2.
Wang Y; Li B; Zhang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1797-1807. PubMed ID: 31062620
[TBL] [Abstract][Full Text] [Related]
14. A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria barbata D. Don.
Wang L; Chen W; Li M; Zhang F; Chen K; Chen W
J Ethnopharmacol; 2020 May; 254():112260. PubMed ID: 31577937
[TBL] [Abstract][Full Text] [Related]
15. Extraction Optimization, Structural Characterization, and Anti-Hepatoma Activity of Acidic Polysaccharides From
Su W; Wu L; Liang Q; Lin X; Xu X; Yu S; Lin Y; Zhou J; Fu Y; Gao X; Zhang B; Li L; Li D; Yin Y; Song G
Front Pharmacol; 2022; 13():827782. PubMed ID: 35444545
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia.
Huang Z; Yang Y; Fan X; Ma W
Front Pharmacol; 2022; 13():952677. PubMed ID: 36160389
[No Abstract] [Full Text] [Related]
18. Molecular Targets and Mechanisms of
Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
[TBL] [Abstract][Full Text] [Related]
19. [Material basis and mechanism of Huangqin Tea in prevention of colorectal cancer based on network pharmacology and molecular docking].
Wang Y; Shen J; He Q; Yang KL; He CN; Xiao PG
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6251-6260. PubMed ID: 34951252
[TBL] [Abstract][Full Text] [Related]
20. [Material basis and mechanism of Xiao'er Resuqing Oral Liquid on hand, foot and mouth disease based on network pharmacology and molecular docking].
Xu YL; Guo SS; Cui XL; Shi YJ
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5745-5752. PubMed ID: 33496115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
